Skip to main content
. 2018 Nov 21;26(2):217–222. doi: 10.1111/iju.13842

Figure 1.

Figure 1

Detection rates of clinically significant prostate cancer according to the CSPC risk stratification for patients with PI‐RADS categories 4 and 5. *Statistically significant with a P < 0.0001. **Statistically significant with a P < 0.0001. ***Statistically significant with a P < 0.0001.